No Data
No Data
AFT Pharmaceuticals Signs Brazil Licensing Agreement for Maxigesic IV
AFT Pharmaceuticals (NZE:AFT, ASX:AFP) signed a licensing agreement with Brazilian hospital injectables manufacturer Halex Istar for its proprietary pain relief medicine Maxigesic IV, according to a W
New Zealand Shares Rise on US Earnings Rally; AFT Pharmaceuticals to Develop Topical Scar Treatment
New Zealand shares rose on Wednesday's close, following a US rally caused by better-than-expected earnings reports from megacap companies. The S&P/NZX 50 Index jumped 1.21% or 143.15 points to close a
AFT Pharmaceuticals, Massey Ventures, Gillies McIndoe Research Institute Partner to Develop Topical Scar Treatment
AFT Pharmaceuticals (NZE:AFT, ASX:AFP) teamed up with Massey University's commercialization arm, Massey Ventures, and charitable foundation Gillies McIndoe Research Institute to develop a topical trea
New Zealand Shares Close Flat on Monday; Fletcher Building Chair Steps Down
New Zealand shares were flat on Monday's close as investors mostly kept to the sidelines to weigh in on the most recent trade release. The S&P/NZ50 Index changed little to close at 11,724.21. Stats NZ
AFT Pharmaceuticals to Expand Global Footprint With Signing of Supply, Production Deals
AFT Pharmaceuticals (NZE:AFT) is set to expand its global footprint following the signing of supply agreements and production deals, the pharmaceutical firm said on Monday. The pharma company signed a
New Zealand Shares Rebound on Friday Close; AFT Pharmaceuticals Raises Operation Profit Guidance
New Zealand shares rebounded on Friday's close as the January manufacturing activity read provided a glimmer of hope for an eventual recovery. The S&P/NZ50 Index rose 0.73% or 84.44 points to close at
No Data